國立虎尾科技大學 |

Cutaneous Drug Hypersensitivity = Clinical Features, Mechanisms, Diagnosis, and Management /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Cutaneous Drug Hypersensitivity/ edited by Andreas J. Bircher, Howard I. Maibach, Knut Brockow, Annick Barbaud.
其他題名:	Clinical Features, Mechanisms, Diagnosis, and Management /
其他作者:	Bircher, Andreas J.
面頁冊數:	XXXII, 337 p. 67 illus., 52 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Dermatology. -
電子資源:	https://doi.org/10.1007/978-3-030-82743-4
ISBN:	9783030827434

Cutaneous Drug Hypersensitivity = Clinical Features, Mechanisms, Diagnosis, and Management /
Cutaneous Drug HypersensitivityClinical Features, Mechanisms, Diagnosis, and Management /[electronic resource] :edited by Andreas J. Bircher, Howard I. Maibach, Knut Brockow, Annick Barbaud. - 1st ed. 2022. - XXXII, 337 p. 67 illus., 52 illus. in color.online resource.

Part I. General aspects of drug hypersensitivity -- Chapter 1. Terminology, classifications, chronology -- Chapter 2. Epidemiology -- Chapter 3. Clinical manifestations: Cutaneous signs and syndromes -- Chapter 4. Clinical manifestations: Other organs (kidney, gut, heart, brain etc.) -- Chapter 5. Danger signs in drug hypersensitivity and severity SCORES -- Chapter 6. Pathomechanisms in Drug Hypersensitivities -- Part II. Diagnostic methods -- Chapter 7. Skin tests -- Chapter 8. Serological tests -- Chapter 9. T cell tests -- Chapter 10. Basophil activation tests -- Chapter 11. Histopathology of drug induced exanthemas -- Part III. Management -- Chapter 12. Drug desensitization in immediate-type hypersensitivity -- Chapter 13. Documentation allergy card/pass -- Part IV. Drug hypersensitivity in specific populations -- Chapter 14. Children and Adolescents -- Chapter 15. HIV-Infection and AIDS -- Chapter 16. Oncology. immune checkpoint Inhibitors -- Chapter 17. MC releasing syndromes in drug hypersensitivity -- Part V. Eliciting Drugs -- Chapter 18. Penicillins -- Chapter 19. Cephalosporin Allergy -- Chapter 20. Other Antibiotics -- Chapter 21. Other Antiinfectious drugs -- Chapter 22. Analgesics and non-steroidal antiphlogistic drugs -- Chapter 23. Periinterventional hypersensitivity: Anesthetic drugs and materials -- Chapter 24. Muscle relaxants -- Chapter 25. Anticoagulants -- Chapter 26. Biological drugs -- Chapter 27. Hormones (delayed) -- Chapter 28. Vaccines -- Chapter 29. Antiepileptic and psychotropic drugs -- Chapter 30. PROTON PUMP INHIBITORS -- Chapter 31. Diagnostic agents -- Chapter 32. Hypersensitivity to blood pressure agents -- Chapter 33. Iron preparations -- Chapter 34. Vitamins and supplements -- Chapter 35. Anti-tumor drugs / Cytostatics -- Chapter 36. Photosensitizing drugs -- Chapter 37. Topically applied drugs -- Chapter 38. Additives: Preservatives, Antioxidants (sulfites), Colors, dyes and other.

This book covers all aspects of hypersensitivity to drugs, providing practical information for non-specialist physicians as well as addressing issues of interest to practitioners in different specialties and presenting the expert knowledge required by specialist allergists and immunologists. The opening, general section discusses basics such as clinical manifestations, histopathology, mechanisms, risk factors, drug hypersensitivity in particular populations, and the full range of diagnostic methods. The second part of the book provides concise information on the most important drug classes and guides the reader on how to proceed when patients present with a suspected reaction. For each drug class, the current level of evidence for use of the different diagnostic tools, including skin tests, provocation tests, and in vitro tests, is clarified, and management options, outlined. The inclusion of helpful tables and algorithms is designed to aid in decision making. Drug hypersensitivity is among the more complex allergological issues, and this book will meet the needs of general practitioners, internists, and specialists.

ISBN: 9783030827434

Standard No.: 10.1007/978-3-030-82743-4doiSubjects--Topical Terms:

669082
Dermatology.

LC Class. No.: RL1-803

Dewey Class. No.: 616.5

Cutaneous Drug Hypersensitivity = Clinical Features, Mechanisms, Diagnosis, and Management /
LDR:04510nam a22003975i 4500 001 1088383
003 DE-He213
005 20220709122655.0
007 cr nn 008mamaa
008 221228s2022 sz | s |||| 0|eng d
020 $a 9783030827434 $9 978-3-030-82743-4
024 7 $a 10.1007/978-3-030-82743-4 $2 doi
035 $a 978-3-030-82743-4
050 4 $a RL1-803
072 7 $a MJK $2 bicssc
072 7 $a MED017000 $2 bisacsh
072 7 $a MJK $2 thema
082 0 4 $a 616.5 $2 23
245 1 0 $a Cutaneous Drug Hypersensitivity $h [electronic resource] : $b Clinical Features, Mechanisms, Diagnosis, and Management / $c edited by Andreas J. Bircher, Howard I. Maibach, Knut Brockow, Annick Barbaud.
250 $a 1st ed. 2022.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a XXXII, 337 p. 67 illus., 52 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Part I. General aspects of drug hypersensitivity -- Chapter 1. Terminology, classifications, chronology -- Chapter 2. Epidemiology -- Chapter 3. Clinical manifestations: Cutaneous signs and syndromes -- Chapter 4. Clinical manifestations: Other organs (kidney, gut, heart, brain etc.) -- Chapter 5. Danger signs in drug hypersensitivity and severity SCORES -- Chapter 6. Pathomechanisms in Drug Hypersensitivities -- Part II. Diagnostic methods -- Chapter 7. Skin tests -- Chapter 8. Serological tests -- Chapter 9. T cell tests -- Chapter 10. Basophil activation tests -- Chapter 11. Histopathology of drug induced exanthemas -- Part III. Management -- Chapter 12. Drug desensitization in immediate-type hypersensitivity -- Chapter 13. Documentation allergy card/pass -- Part IV. Drug hypersensitivity in specific populations -- Chapter 14. Children and Adolescents -- Chapter 15. HIV-Infection and AIDS -- Chapter 16. Oncology. immune checkpoint Inhibitors -- Chapter 17. MC releasing syndromes in drug hypersensitivity -- Part V. Eliciting Drugs -- Chapter 18. Penicillins -- Chapter 19. Cephalosporin Allergy -- Chapter 20. Other Antibiotics -- Chapter 21. Other Antiinfectious drugs -- Chapter 22. Analgesics and non-steroidal antiphlogistic drugs -- Chapter 23. Periinterventional hypersensitivity: Anesthetic drugs and materials -- Chapter 24. Muscle relaxants -- Chapter 25. Anticoagulants -- Chapter 26. Biological drugs -- Chapter 27. Hormones (delayed) -- Chapter 28. Vaccines -- Chapter 29. Antiepileptic and psychotropic drugs -- Chapter 30. PROTON PUMP INHIBITORS -- Chapter 31. Diagnostic agents -- Chapter 32. Hypersensitivity to blood pressure agents -- Chapter 33. Iron preparations -- Chapter 34. Vitamins and supplements -- Chapter 35. Anti-tumor drugs / Cytostatics -- Chapter 36. Photosensitizing drugs -- Chapter 37. Topically applied drugs -- Chapter 38. Additives: Preservatives, Antioxidants (sulfites), Colors, dyes and other.
520 $a This book covers all aspects of hypersensitivity to drugs, providing practical information for non-specialist physicians as well as addressing issues of interest to practitioners in different specialties and presenting the expert knowledge required by specialist allergists and immunologists. The opening, general section discusses basics such as clinical manifestations, histopathology, mechanisms, risk factors, drug hypersensitivity in particular populations, and the full range of diagnostic methods. The second part of the book provides concise information on the most important drug classes and guides the reader on how to proceed when patients present with a suspected reaction. For each drug class, the current level of evidence for use of the different diagnostic tools, including skin tests, provocation tests, and in vitro tests, is clarified, and management options, outlined. The inclusion of helpful tables and algorithms is designed to aid in decision making. Drug hypersensitivity is among the more complex allergological issues, and this book will meet the needs of general practitioners, internists, and specialists.
650 0 $a Dermatology. $3 669082
650 0 $a Allergy. $3 645199
650 0 $a Internal medicine. $3 644638
650 0 $a Pharmacovigilance. $3 1163244
650 0 $a Primary care (Medicine). $3 1254357
650 0 $a Family medicine. $3 644327
650 2 4 $a Allergology. $3 673940
650 2 4 $a Internal Medicine. $3 668583
650 2 4 $a Drug Safety and Pharmacovigilance. $3 1064651
650 2 4 $a Primary Care Medicine. $3 673694
650 2 4 $a General Practice and Family Medicine. $3 1366021
700 1 $a Bircher, Andreas J. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1395563
700 1 $a Maibach, Howard I. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 582954
700 1 $a Brockow, Knut. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1395564
700 1 $a Barbaud, Annick. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1395565
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030827427
776 0 8 $i Printed edition: $z 9783030827441
776 0 8 $i Printed edition: $z 9783030827458
856 4 0 $u https://doi.org/10.1007/978-3-030-82743-4
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)